Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.
about
Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidenceA hostel for the hostile: the bone marrow niche in hematologic neoplasmsThe increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemiaHigh expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology groupFunctional and structural insights into ASB2alpha, a novel regulator of integrin-dependent adhesion of hematopoietic cellsHigh VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.Performance status in elderly patients with acute myeloid leukemia: exploring gene expression signatures of cytokines and chemokines.Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia.Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupA phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemiaThe regulation of normal and leukemic hematopoietic stem cells by niches.Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group.Role of leukemia cell invadosome in extramedullary infiltration.The role of natalizumab in hematopoietic stem cell mobilization.Targeting the microenvironment in acute myeloid leukemia.Myeloid malignancies and the microenvironment.VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.Targeting myelogenous leukemia stem cells: role of the circulation.The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
P2860
Q26770388-24F30B7A-30C0-47FA-ACD0-EE7C2E36841AQ26777629-0C8666C8-3C09-4EFC-8648-80651F2CEEB1Q28479144-BF6B34AC-93E4-4FEF-A9AD-B2F2C5075856Q33990843-50AF6D52-025A-4A16-9857-4BF9684FC7DDQ35182907-3F15527C-6421-472C-BB25-00B54FB23A85Q35528643-87D14E90-2BB1-4828-A99C-C98A743BC097Q35661799-39492F71-DA56-4A97-B513-6D7405FD8B43Q35690746-1CD2DB30-5ACD-4128-B47D-DCE0BC15482AQ35786301-7EA00566-5B21-4D62-AE0B-8CA8FCCD973DQ35862717-C252BE4F-7078-4122-ADB4-4D4208C899D3Q35953355-A48363C4-708D-47A6-A934-5C5E83A8C1E1Q36284911-236CF6A1-95B7-41FD-ABC9-36DD485EE054Q36666787-1B6AF4A5-8F2D-4236-9B97-59663C7A95B4Q37131922-DA1E97AF-CC4F-4021-985A-272E4D920FE0Q37373047-B03B97E9-73D8-4AE6-A3E2-7B8F7FB3F8F8Q37536053-34C550FA-F4B3-4C6C-A42E-5AB078AAFB79Q38447268-C2364165-1F32-4DC9-946D-86608CC45426Q39073878-642BAF5F-80B1-4437-8DD2-4F649DB327F6Q41602417-45372747-AA6D-43A9-8EF8-2717C47E192EQ41860215-04540D4F-95DA-4FE3-B4EB-8D1F5E72D03BQ49176545-AC6E6A49-06E5-4E57-A4D4-D053952C987AQ55354182-E572DD06-CF73-4294-9353-631986B0177CQ55712500-B08E682F-553D-4C97-968F-3756681AD2DC
P2860
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Very late antigen-4 function o ...... s with acute myeloid leukemia.
@en
Very late antigen-4 function o ...... s with acute myeloid leukemia.
@nl
type
label
Very late antigen-4 function o ...... s with acute myeloid leukemia.
@en
Very late antigen-4 function o ...... s with acute myeloid leukemia.
@nl
prefLabel
Very late antigen-4 function o ...... s with acute myeloid leukemia.
@en
Very late antigen-4 function o ...... s with acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Very late antigen-4 function o ...... s with acute myeloid leukemia.
@en
P2093
Adrianne N Wilks
Cheryl L Willman
Derek L Stirewalt
John M Harlan
Kenneth J Kopecky
Pamela S Becker
Sylvia Chien
Thalia Papayannopoulou
P2860
P304
P356
10.1182/BLOOD-2007-12-124818
P407
P577
2008-10-16T00:00:00Z